Data
The tested compounds are listed bellow with the determined Michaelis constant Km, inhibition constant Ki and inhibition type.
|
Compounds |
Km [µM] |
Ki [µM] |
Type of inhibition and Remarks |
1 |
|
70 |
1.4 |
Uncompetitive |
2 |
|
62 |
319 |
Uncompetitive |
3 |
|
44 |
14.5 |
Uncompetitive |
4 |
|
61 |
16.4 |
Competitive |
5 |
|
61 |
337 |
Uncompetitive |
6 |
|
61 |
28'000 |
Competitive |
7 |
|
60 |
44'000 |
Mixed |
8 |
|
60 |
5'520 |
Uncompetitive |
9 |
|
54 |
328 |
Uncompetitive |
10 |
|
43 |
15'000 |
Competitive |
11 |
|
76 |
3'680 |
Uncompetitive |
12 |
|
39 |
39'500 |
Competitive |
13 |
|
45 |
X |
No inhibitor |
14 |
|
45 |
24'900 |
Uncompetitive |
15 |
|
-- |
-- |
Hydrolyses in the testing conditions! Ki value larger than compound 2 |
16 |
|
-- |
-- |
Hydrolyses in the testing conditions! Ki value larger than compound 2 |
17 |
|
-- |
-- |
Slow-binding |
18 |
|
-- |
-- |
Formation of pyrrole with 5-aminlevulinic acid. Not possible to test! |
19 |
|
-- |
-- |
UV absorption in the range used for the pyrrole formation determination |
20 |
|
-- |
-- |
UV absorption in the range used for the pyrrole formation determination |
All the compounds are drawn in their diketo form. In solution they are present as a mixture of the keto and the enol form. The following table gives the percentage of the enol form present in CDCl3 as determined by 1H-NMR. The determinations of the enol content were performed using concentrations comprised between 5 and 20 mM.
compounds |
1 |
2 |
3 |
4 |
5 |
8 |
9 |
10 |
11 |
Enol % |
90 |
71 |
81 |
97 |
90 |
61 |
98 |
41 |
85 |